SCHEMBL29352991

SCHEMBL29352991

Nc1ccc(Nc2ccc(C(=O)O)cc2)c2c1C(=O)c1ccccc1C2=O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 6/20 0.61
▸ MEN1 O00255 5/20 0.61
▸ MMP14 P50281 1/20 0.61
▸ P2RY4 P51582 3/20 0.61
▸ MAPT P10636 5/20 0.54
▸ KDM4E B2RXH2 3/20 0.54
▸ HPGD P15428 2/20 0.54
▸ GAA P10253 2/20 0.54
▸ THRB P10828 2/20 0.54
▸ ALDH1A1 P00352 1/20 0.54
▸ HSD17B10 Q99714 1/20 0.54
▸ NPC1 O15118 3/20 0.53
▸ MAPK1 P28482 3/20 0.53
▸ NPSR1 Q6W5P4 3/20 0.53
▸ RAB9A P51151 2/20 0.53
▸ L3MBTL1 Q9Y468 2/20 0.53
▸ HK1 P19367 1/20 0.53
▸ CDC25A P30304 1/20 0.53
▸ CDC25B P30305 1/20 0.53
▸ CDC25C P30307 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10790208 1.00 KMT2A (0.61) KMT2AMEN1MMP14P2RY4MAPT
SCHEMBL10793604 0.92 P2RY4 (0.62) KMT2AMEN1MMP14P2RY4MAPT
SCHEMBL10789018 0.90 P2RY4 (0.60) KMT2AMEN1P2RY4MAPTKDM4E
SCHEMBL169365 0.87 ADORA2A (0.63) KMT2AMEN1MMP14P2RY4MAPT
SCHEMBL30918998 0.87 ADORA2A (0.63) KMT2AMEN1MMP14P2RY4MAPT
SCHEMBL29527792 0.87 ADORA2A (0.63) KMT2AMEN1MMP14P2RY4MAPT
SCHEMBL10791991 0.85 MAPT (0.64) KMT2AMEN1P2RY4MAPTKDM4E
SCHEMBL10790230 0.85 KMT2A (0.58) KMT2AMEN1MMP14P2RY4MAPT
SCHEMBL1994395 0.85 P2RY12 (0.60) KMT2AMEN1MMP14P2RY4MAPT
SCHEMBL4704714 0.84 ADORA2A (0.59) KMT2AMEN1MMP14P2RY4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119619337-A Method for detecting nicotine content in tobacco leaves 湖北省烟草公司宜昌市公司 2025-03-14 — — CN claimed
US-20220115236-A1 METHOD AND APPARATUS TO ELIMINATE CONTAMINANT PARTICLES FROM AN ACCELERATED NEUTRAL ATOM BEAM AND THEREBY PROTECT A BEAM TARGET EXOGENESIS CORPORATION (US) 2022-04-14 — — US claimed
CN-113963951-A Dielectric material, method of manufacturing the same, device including the same, and memory cell 三星电子株式会社 2022-01-21 — — CN claimed
US-12610553-B2 Semiconductor device and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2026-04-21 — — US disclosed
US-20260048132-A1 IMIDAZOLYL GOLD COMPOUNDS FOR THE TREATMENT OF LUNG CANCER UNIV CINCINNATI (US) 2026-02-19 — — US disclosed
EP-4651705-A1 METHOD Nicoventures Trading Limited (GB) 2025-11-26 — — EP disclosed
EP-4649147-A2 TYPE II CAS PROTEINS AND APPLICATIONS THEREOF Alia Therapeutics Srl (IT) 2025-11-19 — — EP disclosed
US-12458528-B2 Pure polyurethane condom having adhesive layer, and preparation method therefor Reckitt Benckiser Health Limited (GB) 2025-11-04 — — US disclosed
US-20250304984-A1 METHOD OF MODULATING THE ALKALOID CONTENT OF TOBACCO Nicoventures Trading Limited (GB) 2025-10-02 — — US disclosed
EP-4619535-A1 TYPE II CAS PROTEINS AND APPLICATIONS THEREOF Alia Therapeutics Srl (IT) 2025-09-24 — — EP disclosed
US-20250283101-A1 METHOD OF MODULATING THE ALKALOID CONTENT OF TOBACCO Nicoventures Trading Limited (GB) 2025-09-11 — — US disclosed
US-11399500-B2 Tobacco inbred and hybrid plants and uses thereof NORTH CAROLINA STATE UNIVERSITY (US) 2022-08-02 — — US disclosed
WO-2022159751-A1 ACCELERATED NEUTRAL ATOM BEAM (ANAB) MODIFIED POLYPROPYLENE FOR REDUCING BACTERIA COLONIZATION WITHOUT ANTIBIOTICS EXOGENESIS CORPORATION (US) 2022-07-28 — — WO disclosed
EP-4022303-A1 MACHINE OLFACTION SYSTEM AND METHOD X Development LLC (US) 2022-07-06 — — EP disclosed
CN-114641572-A Identification of resistance genes from wild relatives of bananas and their use in the control of Panama disease EG农作物科学股份有限公司 2022-06-17 — — CN disclosed
WO-2022084782-A1 SEMICONDUCTOR DEVICE AND ELECTRONIC APPARATUS 株式会社半導体エネルギー研究所 2022-04-28 — — WO disclosed
WO-2022087441-A2 B AND T LYMPHOCYTE ATTENUATOR (BTLA) MODULATORS AND METHOD OF USING SAME ANAPTYSBIO, INC. (US) 2022-04-28 — — WO disclosed
CN-110669839-B Artificial simulated molecular beacon and kit for detecting EGFR gene T790M mutation 北京福安华生物科技有限公司 2022-04-15 — — CN disclosed
US-20220115236-A1 METHOD AND APPARATUS TO ELIMINATE CONTAMINANT PARTICLES FROM AN ACCELERATED NEUTRAL ATOM BEAM AND THEREBY PROTECT A BEAM TARGET EXOGENESIS CORPORATION (US) 2022-04-14 — — US disclosed
CN-113963951-A Dielectric material, method of manufacturing the same, device including the same, and memory cell 三星电子株式会社 2022-01-21 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12610553-B2 Semiconductor device and electronic device ITK, TESK1, TRHDE KMT2A 2803/4885MEN1 1066/4885MMP14 2599/4885
US-20260048132-A1 IMIDAZOLYL GOLD COMPOUNDS FOR THE TREATMENT OF LUNG CANCER KRAS, NRAS, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 KMT2A 1882/4885MEN1 545/4885MMP14 4278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback